Autoimmune hepatitis: Azathioprine or mycophenolate mofetil for inducing remission?

We read with interest the first randomized-controlled trial evaluating the safety and efficacy of mycophenolate mofetil (MMF) as the first-line over azathioprine (AZA) for induction of adult-onset autoimmune hepatitis (AIH)1 and would like to raise the following points.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research